Cargando…
Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report
INTRODUCTION: Tyrosine kinase inhibitors (TKI) targeting epidermal growth factor receptor (EGFR) are approved for use in metastatic non-small cell lung cancer (NSCLC). CASE PRESENTATION: Here we present a case of a African American patient with stage IIIA NSCLC treated with osimertinib in the neoadj...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066434/ https://www.ncbi.nlm.nih.gov/pubmed/33892800 http://dx.doi.org/10.1186/s13256-021-02748-y |